OSEHRA Immunization Work Group Meeting Minutes
MEETING DETAILS
DATE:
Thursday, October 1, 2015
MS LYNC:
650-479-3207 & Online Meeting
MEETING
LEAD:
Nancy Anthracite
TIME:
4:00 PM EST
ACCESS
CODE(S):
660 146 910
FACILITATOR: Liz Badt
SCRIBE:
Jacquie Marian
INVITEES:
See below.
ATTENDEES & ROLES
ATTENDED
X
LAST NAME
FIRST NAME
ROLE
Anthracite
Nancy
President, CMO & Director,
WorldVistA
Arzt
Noam
HLN Consulting
Avery
Keith
VIMM PMO MUMPS Developer
Avila
Rick
VA Senior Advisor to CIO
X
Badt
Liz
OSEHRA Admin
X
Chertcoff
Daryl
HLN Consulting
Davis
Shelita
VIMM PMO Technical Writer
Groom
Amy
IHS OIT
Habiel
Sam
Director of Technology, VistA
Expertise Network
Hebert
Linda
VA Immunization SME
X
Page 1 of 7
Henderson
Mike
OSEHRA Director Open Source
Product Management
Johnson
Brett
Chief Integrator, One Million Solutions
in Health
Kemp
Dennis
VIMM PMO Project Manager
X
Li
Peter
OSEHRA CISSP Director, Engineering
X
Lilly
George
VistA Expertise Network & CIO,
WorldVistA
Love
Tom
Cimarron Infomatics
X
Magoon
Keith
VA VIMM Project Manager
X
Marian
Jacquie
VIMM PMO Business Analyst
Montali
Michael
VA Developer Competency Manager
Morgan
Brian
VIMM PMO SME
Puleo
Anthony
VA CPRS
Peterson
Dennis
VA VLER Health Project Manager
Redington
Patrick
VA M Developer
Remillard
Mike
IHS Software Developer
Rhodes
Chris
Director, Open Source VHA
Richards
Susan
IHS Office of Information
Ruslavage
Michelle
IHS OIT
Schlehuber
Cameron
Community volunteer, Former DBA for
VistA
Silverman
Rob
VA Immunization SME
Steele
Kathy
VIMM PMO Technical Writer
Suralik
Mike
HLN
Volpp
Bryan
VA Informatics SME
X
Page 2 of 7
X – Present. O – Excused absence. Blank – no report.
MEETING TOPICS
PRESENTER: Keith Magoon / Rob Silverman
TOPIC: Update on Immunization Project
DISCUSSION:




Keith stated PX206 and PX209 have been installed in over 100 facilities. The
compliance date is October 4th.
Completed PX210 and submitted to IOC Entry; just polishing up documentation.
Hopefully, within 10 to 12 business days IOC will begin.
o Keith stated the last defect was not a defect. When it was tested with the
test engineers and developers, the results were as expected and defect
14 did not need remediated.
Keith stated the acquisition for ICE and CAT is still moving forward; kickoff
meeting for the acquisition was held today. 508 conformance testing of CAT is
still in progress; the latest report was sent to Noam and Mike Suralik as
informational only so they can review and understand what the government
needs for 508.
o Nancy asked in general how long it takes to complete meetings on these
sorts of acquisitions.
o Keith stated The Acquisition Center (TAC) is very busy at this time of the
year and has notified them he would like the acquisition as soon as
feasible. No date can be provided at this time.
Rob stated there are a couple of requirements from the original VA and DOD
discussions that he is looking for input on what we want to do with them from a
VA, VistA, and open source standpoint.
o “The system SHALL render a list of vaccine noted to be ineffective for the
patient in the past (e.g. Hepatitis B)” and “The system shall provide the
ability to render a notification when a titer is required after the completion
of an immunization series (e.g., hepatitis B)”.
o Rob stated he remembers the discussions that lead to this and it was not
just Hepatitis as an example. This was a DOD request very specific about
Hepatitis that sometimes even after completing the series the result is a
low titer and insufficient evidence of immunity.
o Rob asked from a VA, VistA, open source, and IHS standpoint what we
might want to do about that original requirement request.
 Nancy stated that it would have a broader potential interest
because of the healthcare worker screenings for measles, mumps,
and rubella immunity for example and whether they need boosters.
It would be smart to approach it from a more generalized point of
view and this could just be a specific example.
 For example, healthcare workers that got immunized for hepatitis
back 20 years ago and a titer is done and it looks like they don’t
Page 3 of 7


have a protective titer; they do very well when you give them a
booster shot.
o Rob asked if there are specific immunizations that were more commonly
used for than others; Nancy stated rabies, measles, mumps, rubella, and
hepatitis B. Potentially, Pertussis which is not being done right now, but
know that the immunity tends to wane and there is always discussion as to
whether T-dap should be done again or just one time. Also rabies vaccine
for those in situations where they need to be immunized.
Nancy asked if Keith had any updates or information about the meeting between
George, Anthony, and the VA developer about the code from open source. Keith
stated he did not attend and it was strictly a developer to developer meeting.
o Keith stated it will probably be a situation where once Keith Avery
understands the code, it will be put into our development and testing
environment and see how it functions. It might not be the best way to
proceed, but it would be better than trying to review over 8,000 lines of
code.
o George stated he felt the meeting went well and believes Keith Avery
understands a lot and asked some very good questions. Keith A. left the
door open for them to have another meeting where he could go deeper
into the code. George was able to provide information beyond what was
in the code; he pointed Keith A. to some Kernel routines that could be
used instead of what he used.
o George agrees that nothing speaks louder than working code and believes
Keith M.’s approach to getting some code working and installed in order to
see where we stand is great.
o Keith M. stated the support from George and Anthony has been
outstanding; this is the type of collaboration he has looked forward to for
moving forward not just for VIMM, but any other project. This is what
Keith has worked for over the past 2 years in order to ensure
collaborations are benefitting everybody
o Nancy stated this marks another milestone in the effort to collaborate
because we are not only having these meetings but we actually have
developers talking to developers; this is very good that this has finally
happened.
Nancy asked for a status of eHMP v1.3.
o Keith stated VIMM is in meetings with them and have been asked to
provide them with API(s) and RPC(s) they requested in order to extract
immunization information from the PCE package by October 9th. That
coding is more than 50% complete.
o Keith stated Anthony is reviewing the requested eHMP API(s) and RPC(s)
to see if those would be sufficient for CPRS v32.
o Nancy stated she assumed the forecasting is not part of what they are
asking for right now. Keith stated eHMP is asking for the information to
display to the clinician. If you mean the Clinical Decision Support system
when you are asking about forecasting, then that is the code that Keith
Avery is reviewing and working on. eHMP has not asked for the
Page 4 of 7

integration software between VistA and ICE yet. Keith stated he hopes to
have that in our development environment for testing before they request
it.
o Nancy asked what the status of whether Clinical Decision Support
software is going to be used in CPRS and when that will be needed. Keith
stated the outputs of ICE will also be provided to CPRS and he has
already discussed this with that team and their project manager.
o Keith stated VIMM is working on the inputs to ICE; the outputs of ICE
would be eHMP coding that will also be provided to CPRS.
o Keith explained eHMP is responsible for hosting the solution as well as the
interfaces and will be providing the outputs of ICE to CPRS. CPRS v32 is
aware they will need to do some coding to take those outputs from ICE
and display them to a clinician. CPRS v32 is well behind eHMP v1.3 so
eHMP will have it first.
o Keith stated eHMP v1.3 is supposed to be deployed in March 2016.
CPRS v32 is to be in beta testing in March 2016 and go to National
Release in July 2016.
o Keith stated he could provide the data points since the outputs are on
HLN’s website, but he could not provide the IP address or port. It cannot
be tested right now since it is not available on an environment yet.
Nancy stated there is one aspect that has not been discussed is if a vaccine is
determined to be “bad” and would invalidate the immunization as being given and
prevent it from being sent to ICE.
o Rob stated the question is on which side the recommended business logic
takes place. Does the logic take place on the VistA side by suppressing it
on the build for the VMR or does it take place on the ICE side by looking
at it and treating as an invalid dose like you would one too early or too
late?
 Nancy stated she did not believe we had a place on the VistA side
to record that sort of information.
 Rob agreed and asked if this is a good finding and discussion that
we will make a business requirement for it.
o Sam stated it was the Dose Override (#.08) was ported over to the V
IMMUNIZATION data dictionary and noted as not used for VA.
o After Rob reviewed the data dictionary, he suggested asking Mike
Rumillard what the ‘0’ FOR @ means for this field. Sam stated he could
ask Mike.
o George stated from a programmer’s point of view the @ is to delete; so a
zero would delete the entry.
PRESENTER: All
TOPIC: Open Forum
DISCUSSION:
Page 5 of 7



Nancy stated she is working on getting 508 training accessible to the open
community again. Nancy stated Chris Rhoades would see what she can find out
about getting access to the 508 training available outside the VA.
o Keith stated just like we make PMAS and ProPath available to vendors on
the Virtual Office of Acquisition (VOA) site we should make any Section
508 documentation or training available.
Sam stated he wanted to ask about the Vaccine Series information and it is being
pushed out by the Master File Server (MFS). From the last that he heard, the
MFS is not pushing out to the FOIA instance yet.
o George stated the August FOIA is up to date with the MFS and might
include updates to the immunization files, but anything after the August
FOIA was released would not be included.
o Sam confirmed the vaccine series information is there.
Sam stated he has gotten 2 more of the reports to work and demonstrated them
to the group. The system can now run through all the adults on the system and
determine who has had their pneumovax and who has not. He is focusing on
working on the documentation.
o Also wants to write a paper on his experience of porting a full RPMS
application to VistA in addition to the installation and configuration guide.
o He has a release and has tested it and will be writing the manual based on
it.
o Keith stated if the KIDS build and documentation is sent to him in an email
is acceptable.
 Nancy stated it used to be that developers were not allowed to
provide code to the VA, but the VA developers can be provided a
website address to access it.
 Sam stated he has a URL for the porting code. Nancy asked Sam
to send the URL to Keith Magoon and let them download it at their
convenience.
o Nancy asked if a report could be executed to display all the patients that
were given a specific lot number. Sam stated yes and demonstrated how
to execute the report.
o Sam demonstrated how to document a lot as expired or “invalid” for a
patient using the Dose Override field, which would then tell the forecaster
that this immunization is invalid and to not count it towards the
immunization history; this made the immunization due for the patient.
ACTION ITEMS
ASSIGNED TO
ASSIGN
DATE
DUE
DATE
ACTION ITEM
Page 6 of 7
DISPOSITION /
STATUS
Page 7 of 7